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INTRODUCTION
Cholangiolocellular carcinoma (CLC) is an ex-
tremely rare malignant liver tumor which was first
defined by Steiner, et al . in 1957 (1). CLC is thought
to be derived from Hering’s canal because tumor
glands of CLC are morphologically similar to cho-
langioles. Hering’s canals are found in portal tracts
of all sizes where they connect with the bile duct.
The small cells of Hering’s canal have a basement
membrane like the more distal portions of the bili-
ary tree but an apical surface that appears similar to
hepatic canalicular membrane. Recently, Theise, et
al . reported that Hering’s canal might be composed
of hepatic stem cells (2). In addition, CLC sometimes
contain a HCC or CCC component within a tumor.
Those findings suggest that CLC might originate
from hepatic stem cells. On the other hand, because
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of its low frequency, clinicopatholigical features of
CLC have not been clarified as yet. Moreover, few
cases have been reported in English literature. We
herein present a case of CLC with its imagings and
clinicopatholigical findings, and review the litera-
ture, especially focusing on hepatic stem cell origin.
CASE REPORT
A 71-year old man with chronic hepatitis C was
referred for an evaluation of an asymptomatic liver
mass that was detected by routine abdominal ultra-
sonography. Serum biochemistry and tumor mark-
ers, such as carcinoembryonic antigen (CEA), al-
pha fetoprotein (AFP), AFP-L 3%, carbohydrate an-
tigen (CA) 19-9, and protein induced by vitamin K
absence-II (PIVKA-II) were within normal range
(Table 1). The early phase of enhanced computed
tomography (CT) showed marked enhancement of
the tumor that measured approximately 1.01.0 cm
in the right lobe of the liver (Fig. 1). The tumor had
homogeneous enhancement on delayed CT. The
margin of the tumor was not clear. On T1- weighted
magnetic resonance imagings (MRIs), the tumor
was low intensity, whereas, on T2 with high inten-
sity. On superparamagnetic iron oxide (SPIO) - en-
hanced liver MRIs, the tumor had marked enhance-
ment with contrast material. On common hepatic
angiography, the entire tumor showed hypervascu-
larity, and pooling on the delayed images. Computed
tomography angiography (CTA) showed the high
density tumor. On computed tomography during
arterial portography (CTAP) images, only the pe-
ripheral lesion of the tumor was enhanced.
Based on those preoperative imagings, the he-
patic tumor was diagnosed to be HCC. The patient
underwent a partial hepatectomy and liver cirrho-
sis was unclear. The tumor was felt in the right lobe
of the liver, which was approximately 1.5 cm, elas-
tic hard, and moved well.
The resected tumor was measured 1015 mm,
whitish in color, solid, not encapsulated, and had
an irregular margin (Fig. 2). Histological findings
revealed that small ductules showing anastomos-
Table 1. Laboratory findings
WBC
RBC
HGB
HCT
PLT
PT
GOT
GPT
ALP
LDH
g-GTP
TP
ALB
5300/ml
396104/ml
13.1g/ml
39.5%
25.710/ml
11.0s
28 IU/L
19 IU/L
138 U/L
157 U/L
67 U/L
7.3g/dl
3.9g/dl
BUN
Cre
ICG-R 15
CEA
CA19-9
PIVKA-II
AFP
Hbs Ag
Hbc Ab
HCV Ab
HCV-RNA
12mg/dl
0.81mg/dl
13%
1.4ng/L
9U/ml
10 mAU/ml
6U/ml
(-)
(-)
(+)
(-)
A B
C D
E F
Fig. 1. (A) A hepatic arterial-phase computed tomography
(CT) shows marked enhancement of the tumor that measured
approximately 1.01.0 cm in the right lobe of the liver. (B) A
portal-phase scan. (C) A delayed-phase scan shows a homoge-
neous hyper attenuating tumor. (D) T1- weighted magnetic reso-
nance imaging (MRI), the tumor is low intensity. (E) T2-
weighted MRI shows the tumor high intensity. (F) Superparamag-
netic iron oxide (SPIO) - enhanced liver MRI show the tumor
marked enhancement with contrast material.
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ing pattern, and composing of a moniliform struc-
ture. Tumor cells proliferated and replaced the sur-
rounding normal tissue. In small areas of the tumor,
relatively big ductules were detected and resem-
bled cholangiocellular carcinoma. Furthermore, the
tumor contained hepatocellular carcinoma (HCC)-
like area. In immunohistochemistry, cytokeratin
(CK) 7, CK20, CAM5.2 was positive in a part of
HCC, and CK19 was negative in CLCs (Fig. 3). C-
kit was positive in part. The patient’s postoperative
recovery was uneventful and he has been doing well
for 12 months after the operation.
A
B
C
D
Fig. 3. Immunohistochemistry shows the tumor was positive
for Cytokeratin (CK) 7 (A), CAM 5.2 (B), and negative for CK
19 (C). Tumor cells express c-kit (D).
A
B
C
Fig. 2. (A) Macroscopic finding. The tumor is measured
1015mm and whitish in color, solid, not encapsulated, and
has irregular margin. (B, C) Microscopic findings. Small duc-
tules show anastomosing pattern, and compose of moniliform
structure. In focal area of the tumor, relatively big ductules are
detected and resembled cholangiocellular carcinoma (B). Fur-
thermore, the tumor contained an HCC-like area (C). (Hema-
toxylin and eosin stains. A :100, B :200).
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DISCUSSION
CLC is an extremely rare primary malignant tu-
mor in the liver, and the frequency is as low as
0.56% in Japan (3). Because of its low frequency,
clinicopatholigical features of CLC have not been
clarified. The clinicopatholigical characteristics and
findings of images were studied on 9 cases of CLC
whose clinical courses were reported in Japan (3,
4). Five of these 9 patients (56%) were infected
with HCV, one (11%) was infected with HBV, and
3 (33%) were negative for both HCV antibody and
HBs antigen (Table 2). This suggests that CLC has
some association with chronic hepatitis, especially
HCV antibody positive (3). Moreover, because many
cases were infected with HCV or HBV, CLC had
been often mistaken as HCC clinically. MRI was
performed on 4 cases, and tumors showed high in-
tensity on T1-weighted MRIs and low intensity on
T2-weighted MRIs in all 4 cases. Angiography was
performed on 7 cases. In 6 cases, the entire tumor
showed hypervascularity. This finding suggests that
hypervascularity is one of the characteristics of CLC.
In many cases, tumors were macroscopically whit-
ish in color (5). Gross appearance of these tumors
resembled CCC. Two cases contained CLC compo-
nent only in histological findings. In the other 3
cases, tumors had HCC components, and another
had CCC components. In the other 3 cases includ-
ing our case, tumors had both components. Hepatic
stem cells, which have the potential to differentiate
into either hepatocytes or cholangio cells, have been
thought to be cholangioles composing Hering’s ca-
nals (6). Because CLC are thought to be derived
from Hering’s canal, CLC is suggested to have plu-
ripotency to proliferate into HCC and/or CCC. In
this case, the tumor has an HCC-like area or CCC-
like area. In addition, c-kit which is positive in im-
mature cells was positive in this case (7, 8). This
findings support the scenario that CLC is derived
from hepatic stem cells. On the other hand, CK19,
which is positive in normal cholangio cells, was
negative in this tumor (9-12). These findings sug-
gest that expressions of keratin in the tumor might
have changed in the process of carcinogenesis. CK19
was positive in HCC-like area of the tumor, and
CAM, which is usually expressed on HCC, was posi-
tive as well. These findings suggest that the tumor
cells were derived from CLC which can differenti-
ate into either HCC or CCC.
The prognosis of CLC was reported to be better
than HCC. A case who survived for 6 years without
recurrence was reported. However, the prognosis
of CLC is not stated clearly yet, because of its lower
frequency.
The diagnosis criteria on imaging have not been
Table 2. Clinicopatholigical features of CLC cases reported in Japan
case age/sex virus
enhancement in
CT MRI angiography
pathology/
immunohistochemistry prognosis
No. 1 69/ M HCV mosaic T1 : low hyper- HCC, CCC combined 36 Months
T2 : high vascularity CK 7 (+) alive
No. 2 67/ M HBV periphery (+) hyper- CLC 33 Months
vascularity CK 7, 19(+) dead
No. 3 61/ M (-) mosaic hyper- HCC combined 40 Months
vascularity CEA, CA 19-9 (+) alive
No. 4 68/ M HCV mosaic hyper- HCC combined 14 Months
vascularity CEA (+) dead
No. 5 61/ M HCV mosaic hyper- CLC 72 Months
vascularity CEA (+) alive
No. 6 63/ F HCV periphery (+) T1 : low no findings HCC reduplicated 18 Months
T2 : high alive
No. 7 54/ F (-) periphery (+) T1 : low CCC combined 3 Months
T2 : high CK 7 (+), CA 19-9 (+) alive
No. 8 58/ M (-) not enhanced HCC, CCC combined 1 Month
CK 7 (+) dead
No. 9 71/ M HCV mosaic T1 : low hyper- HCC, CCC combined 6 Months
T2 : high vascularity CK 7, 20 (+) alive
HCV : hepatitis C virus HBV : hepatitis B virus
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described clearly, so CLC is difficult to diagnose pre-
operatively. Further studies are needed to clarify the
clinical and clinicopatholigical features of CLC.
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